ORIC Pharmaceuticals, Inc.
ORIC
$10.08
$0.232.34%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.36M | -30.02M | -36.31M | -34.57M | -31.96M |
| Total Depreciation and Amortization | 310.00K | 302.00K | 304.00K | 270.00K | 272.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.98M | 5.67M | 3.57M | 3.11M | 2.70M |
| Change in Net Operating Assets | -780.00K | -8.49M | 4.38M | 2.39M | 3.37M |
| Cash from Operations | -30.84M | -32.53M | -28.05M | -28.80M | -25.63M |
| Capital Expenditure | -63.00K | -387.00K | -219.00K | -418.00K | -333.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -76.87M | 22.84M | 42.87M | 23.49M | 18.61M |
| Cash from Investing | -76.93M | 22.45M | 42.66M | 23.07M | 18.28M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 134.72M | 253.00K | 575.00K | 126.00K | 816.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -414.00K | -242.00K | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 134.30M | 11.00K | 575.00K | 126.00K | 816.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.53M | -10.07M | 15.18M | -5.60M | -6.53M |